These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 170227)

  • 21. Methadone in a 30-day detoxification program for narcotic addicts: a critical review.
    Canada AT
    Int J Addict; 1972; 7(4):613-7. PubMed ID: 4349422
    [No Abstract]   [Full Text] [Related]  

  • 22. [Management of opium addicts using opiates and their antagonists].
    Burchard JM
    Nervenarzt; 1972 Oct; 43(10):501-4. PubMed ID: 4564819
    [No Abstract]   [Full Text] [Related]  

  • 23. A controlled comparison of cyclazocine and naloxone treatment of the paroled narcotic addict.
    Hanlon TE; McCabe OL; Savage C; Kurland AA
    Int Pharmacopsychiatry; 1975; 10(4):240-50. PubMed ID: 765293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unit for delivering multiple drug treatment and prevention services.
    Hosp Community Psychiatry; 1975 Oct; 26(10):663-6. PubMed ID: 1201850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naltrexone and cyclazocine. A controlled treatment study.
    Brahen LS; Capone T; Wiechert V; Desiderio D
    Arch Gen Psychiatry; 1977 Oct; 34(10):1181-4. PubMed ID: 911218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclazocine in the treatment of opiate addiction: a review with recommendations.
    Goldstein MJ
    Int J Addict; 1980 Oct; 15(7):939-56. PubMed ID: 6256300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclazocine treatment of opiate dependence: a progress report.
    Resnick RB; Fink M; Freedman AM
    Compr Psychiatry; 1971 Nov; 12(6):491-502. PubMed ID: 5117068
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of heroin addiction. Multimodality approach.
    Kissin B; Sang E
    N Y State J Med; 1973 May; 73(9):1059-65. PubMed ID: 4512163
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacological adjuncts in the treatment of opiate dependence.
    Resnick RB
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
    [No Abstract]   [Full Text] [Related]  

  • 30. On understanding and treating narcotic dependence: a neuropsychopharmacological perspective.
    Ng LK; Szara S; Bunney WE
    Br J Addict Alcohol Other Drugs; 1975 Sep; 70(3):311-24. PubMed ID: 1059467
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of cyclazocine on cocaine self-administration in rats.
    Glick SD; Visker KE; Maisonneuve IM
    Eur J Pharmacol; 1998 Sep; 357(1):9-14. PubMed ID: 9788768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rehabilitation of the heroin addict.
    Conrad HT
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():223-34. PubMed ID: 4447421
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacotherapy of opiate addiction.
    Swanson DA
    S Afr Med J; 1976 May; 50(22):857-9. PubMed ID: 935974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
    Martin WR
    NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
    [No Abstract]   [Full Text] [Related]  

  • 35. Narcotic antagonists: the search accelerates.
    Maugh TH
    Science; 1972 Jul; 177(4045):249-50. PubMed ID: 5041023
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychopathology and mood during heroin use: acute vs chronic effects.
    Mirin SM; Meyer RE; McNamee HB
    Arch Gen Psychiatry; 1976 Dec; 33(12):1503-8. PubMed ID: 999452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Narcotic antagonists: new methods to treat heroin addiction.
    Hammond AL
    Science; 1971 Aug; 173(3996):503-6. PubMed ID: 5564039
    [No Abstract]   [Full Text] [Related]  

  • 39. Personality factors and drug effects in a controlled study of cyclazocine.
    Capone T; Brahen LS; Wiechert V
    J Clin Psychol; 1976 Apr; 32(2):489-95. PubMed ID: 770508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical studies of cyclazocine in the treatment of narcotic addiction.
    Freedman AM; Fink M; Sharoff R; Zaks A
    Am J Psychiatry; 1968 May; 124(11):1499-504. PubMed ID: 4869436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.